1)
www.cdc.gov/ncidod/dhqp/pdf/ar/06_107498_Essentials_Tool_Kit.pdf
2)
Decision
Resources, Inc. “Vancomycin Continues to Dominate MRSA Treatment with up to 76 Percent
of Surveyed Infectious Disease Specialists Indicating That They Use the Agent
as First-Line Treatment for a Range of MRSA Infections.” May 23, 2011.
3)
“Drug-resistant
Streptococcus pneumoniae Disease.” National Center for Immunization
& Respiratory Diseases: Division of Bacterial Diseases, 2010. www.cdc.gov/ncidod/dbmd/diseaseinfo/drugresisstreppneum_t.htm
4)
http://www.cdc.gov/getsmart/antibiotic-use/anitbiotic-resistance-faqs.html
5)
www.medicinenet.com/vancomycin-resistant_enterococci_vre/article.htm
6)
“Diagnosis
and Management of Acute Otitis Media: Clinical Practice Guidelines.” Pediatrics
Vol. 113 No. 5 May 2004, pp. 1451-1465.
7)
Affiliated
Community Medical Centers (ACMC). “Acute Otitis Media.” (2009)
www.acmc.com/careimprovement/pedia_acuteOtitis.cfm
8)
The
physicians’ denigrating attitude toward naturopathic medicine is summed up by
Dr. Paul G. Donohue, M.D. in “How You Can Control Arthritis.” To Your
Good Health, Summer 1992. “When a real cure is devised for a disease, the
old ‘grandma remedies’ rapidly die. But until then, they flourish.” In other
words, ignore any consideration of alternative theories, no matter what
evidence of success exists.
9)
A
small representative sample of media reporting on this topic includes:
“Bacteria Wages War on Antibiotics.” South
Bay Daily Breeze, November 5,
2001, pg B3; Hull, Dr. Janet. “Over-Prescribed Antibiotics.” 8/2007 online
newsletter; “Antibiotics Still Over-prescribed.” Connexion, France’s
English language newspaper, January 25, 2011.; Writing, A. “Treatment for
Extended-spectrum beta-lactamases (ESBL)” at www.ehow.com
10)
Personal
communication with Dr. Tsuyoshi Okada, July 2009.
11)
Kuyumjian,
AG, PharmD, Levine, JF, MD, “A Prospective Study of Antibiotic Cost Containment
in a University Teaching Hospital over a 13-Year Period.” P&T. Vol
27 No 11, November 2002.
12)
Pesach
Shvartzman, chairman.“ Careful prescribing is beneficial.” BMJ 309: 1011
(15 October 1994)
13)
Centor
RM, Meier FA, Dalton HP. “Throat cultures and rapid tests for diagnosis of
group A streptococcal pharyngitis.” Ann Intern Med. 1986
Dec;105(6):892-9. Online at www.ncbi.nlm.nih.gov/pubmed/3535604
14)
Sefton
AM. “Mechanisms of antimicrobial resistance: their clinical relevance in the
new millennium.” Drugs. 2002;62(4):557-66. Online at http://www.ncbi.nlm.nih.gov/pubmed/11893225
15)
The
Sanford Guide to Antimicrobial Therapy is published annually as an excellent
cross-reference to see comparison tables of medications versus particular
microbes and diseases/conditions. See www.sanfordguide.com
16)
Clark
(1997) p. 34.
17)
http://www.sustainabletable.org/issues/antibiotics/#fn15
(2009)
18)
McKenna,
M. presents several articles on FDA and farm antibiotics online at http://www.wired.com/wiredscience/superbug
(2011)
19)
American
Society for Microbiology. "Newly discovered reservoir of antibiotic
resistance genes." ScienceDaily, 20 Oct. 2011. Online at http://www.sciencedaily.com/releases/2011/10/111020164020.htm
20)
“Antimicrobial
Drugs Approved for Use in Food-Producing Animals: 2009 Sales and Distribution
Data Reported by Drug Class.” http://www.livablefutureblog.com/2010/12/new-fda-numbers-reveal-food-animals-consume-lion%E2%80%99s-share-of-antibiotics
21)
Unattributed
article. “Agricultural Antibiotic Use Contributes To 'Super-Bugs' In Humans.” ScienceDaily (July 5, 2005)
22)
http://www.hhs.gov/asl/testify/2010/04/t20100428b.html
23)
http://www.ahi.org/issues-advocacy/animal-antibiotics/
24)
http://www.wired.com/wiredscience/2011/12/fda-ag-antibiotics/
25)
http://articles.latimes.com/2011/apr/16/news/la-heb-meat-bacteria-consumers-20110416
26)
http://www.ra-infection-connection.com/ongoing.htm
specific article
27)
Marion
Nestle. “Food Politics” Online at
http://www.foodpolitics.com/2010/07/two-gao-reports-on-food-safety-at-the-fda/
28)
Expert
Affidavit to the FDA on Safety of Irradiated Food By William W. Au, Ph.D.
October 28, 2001
29)
Bulletin of the World Health
Organization,
41:873-904, 1969. Cosponsored by the US Atomic Energy Commission and the Food
and Drug Administration.
30)
Mutation Research, 80:333-345, 1981.
31)
Morehouse,
KM and Komolprasert V. “Irradiation of Food and Packaging: An Overview.” ACS
Symposium Series 875, Irradiation of Food and Packaging. Chapter 1,
Pages 1-11. (2004) at www.fda.gov
32)
Caulfield
CD, Cassidy JP, Kelly JP. “Effects of Gamma Irradiation and Pasteurization on
the Nutritive Composition of Commercially Available Animal Diets.” J Am
Assoc Lab Anim Sci. 2008 November; 47(6): 61–66. www.ncbi.nlm.nih.gov/pmc/articles/PMC2687132/
33)
Grolichová
M, Dvofiák P, Musilová H. “Employing Ionizing Radiation to Enhance Food. Safety
– a Review.” Acta Vet. Brno 2004, 73: 143-149. Online at actavet.vfu.cz/pdf/200473010143.pdf
34)
Agriculture
Research Service. “Background: Food Irradiation.” December 10, 1997.
35)
www.biovir.com/Images/pdf024.pdf (2000) and
http://wyndmoor.arserrc.gov/Page/2002\7159.pdf
36)
http://worldwidescience.org/topicpages/d/deinococcus+radiodurans+r1.html (2008)
37)
http://medgadget.com/2007/03/the_secrets_of.html
38)
Lee
HS, Sobsey MD. “Survival of prototype strains of somatic coliphage families in
environmental waters and when exposed to UV low-pressure monochromatic
radiation or heat.” Water Res. 2011 Jun;45(12):3723-34. Online at http://www.ncbi.nlm.nih.gov/pubmed/21600626
39)
Osterholm,
M.T. and Potter, M.E. “Irradiation Pasteurization of Solid Foods: Taking Food
Safety to the Next Level.” Emerging Infectious Disease, Vol.
3(4), 1997.
40)
http://www.sustainabletable.org/issues/processing/
(2009)
41)
Use
the search engine at www.mercola.com or
use Google with key words “irradiation” and “beef.”
42)
Moss,
Michael, “Safety of Beef Processing Method is Questioned.” New York Times,
December 30, 2009. Online at http://www.nytimes.com/2009/12/31/us/31meat.html?_r=4
43)
J. Anim. Sci. 2000. 78:2849-2855.
44)
Dr.
Mercola’s proven “Nutrition Plan for Optimal Health” can be found at www.mercola.com/nutritionplan/index.htm.
Comprehensive dietary guidelines as well as lifestyle modifications are
presented which, if diligently followed, will result in improved health and
well-being. A recipe book is also available at this website.
45)
http://www.organicconsumers.org/madcow.cfm
46)
Broxmeyer
L. “Is Mad Cow Disease Caused By a Bacteria?” Medical Hypotheses
(2004) 63, 731–739. Online at http://drbroxmeyer.netfirms.com/MadCow.htm
47)
“What
You Need to Know about Mercury in Fish and Shellfish.” EPA-823-R-04-005. March
2004.
48)
http://emedicine.medscape.com/article/1009464-overview
49)
Historical
timeline at http://tch.ucsd.edu/chem259/259_lecture_02_2008.pdf
50)
Garrett
( 1995) p. 36.
51)
Ibid.,
pp. 428-30.
52)
http://textbookofbacteriology.net/streptococcus.html
(2011)
53)
www.hhv-6foundation.org/associated-conditions/hhv-6-and-multiple-sclerosis.
54)
http://wwwnc.cdc.gov/eid/article/5/3/99-0306_article.htm.
55)
Bureau
of Epidemiology. “Rheumatic Fever in Utah, 1998: When a sore throat isn’t just
a sore throat.” Dept of Health Newsletter, 1998.
56)
Eustice,
C. “Polyarthritis is one of the major criteria associated with rheumatic
fever.” (2006) http://arthritis.about.com/od/othercond/a/
rheumaticfever.htm
57) “Horrible.” Unattributed
feature article. The Economist, May
28, 1994, p. 52.
58)
www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm
59)
Garrett
( 1995) pp. 414-415 and pp. 670-4.
60)
Monmaney,
Terrence. “Antibiotic-Resistant Bugs on the Rise, Federal Study Finds.” Los Angeles Times. Vol. 115, No. 30, p.
2. 8/24/1995.
61)
www.cdc.gov/mmwr/preview/mmwrhtml/00047198.htm
62) Via the Internet at www.cdc.gov
from the CDC Division of Bacterial and Mycotic Diseases. Newly
identified bacterial pathogens with unusual patterns of drug resistance
constitute the focus of this subagency of the CDC.
63)
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/streppneum_t.htm
64)
O’Brien
KL, Wolfson LJ, et al. “Burden of disease caused by Streptococcus pneumoniae in
children younger than 5 years: global estimates.” Lancet 2009; 374:
893–902. Online at www.ncbi.nlm.nih.gov/pubmed/19748398
65) Garrett (1995) pp. 226-233.
66)
Study
results summarized by Lori Oliwenstein. “Understanding T-Cells,” Arthritis Today, January/February 1996.
The scientists, whose experiment was first published in Immunity, speculated that RA patients most likely have another gene
to account for the T-cell difference.
67)
Ewald,
Paul W. “The Evolution of Virulence.” Scientific
American, April 1993.
68)
Invading pathogenic microbes cause severe and rapid depletion of
vitamin C, leading to painful symptoms. See our website article
69)
Chia-Hung
Chiang, et al. “Association Between Mycoplasma Pneumonia and Increased Risk of
Ischemic Stroke.” Online at http://stroke.ahajournals.org/content/early/2011/07/28/STROKEAHA.110.608075
70)
Transposons
were discovered and named by Dr. Barbara McClintock, for which she received the
1990 Nobel Prize in Medicine.
71)
Garrett
(1995) p. 432.
72)
Remarks
by bacteriologist Alexander Tomasz, “Disease Causing Bacteria Resistant to
Antibiotics,” at the annual meeting of the American Association for the
Advancement of Science, San Francisco, February 19, 1994.
73) Some estimates now put this
figure at nearer 40 million.
74)
Streptococcus pneumoniae also has so many different strains that one
exposure does not immunize against the dozens of others.
75)
Taubenberger
JK, Reid AH, et al. “Characterization of the 1918 influenza virus polymerase
genes.” Nature. 2005 Oct 6;437(7060):889-93.
76) Garrett (1995) p. 160.
77)
Broxmeyer
L. “SARS: Just another viral acronym?” (2003) http://drbroxmeyer.netfirms.com/sars.pdf
78) All direct quotes in this
chapter are found in Dr. Baseman, JB, Dr. Tully, JG, “Mycoplasmas: Sophisticated,
Reemerging and Burdened by Their Notoriety.” CDC's Emerg Infect Dis,
1997; 3:1.
79)
Appendix
“Antibiotics: Efficacy Against Susceptible Pathogens.” Physician’s Drug Handbook (2007)
80) The following websites are
very informative about PCR research and tests:
www.gene.com and www.medscape.com.
81)
Overview at www.ra-infection-connection.com/MarshallProtocol.htm
82)
Garrett
(1995) pp. 582-6.
83)
Stein
GE and Craig WA. “Tigecycline: A Critical Analysis.” Clin Infect Dis.
(2006) 43 (4): 518-524. Online at http://cid.oxfordjournals.org/content/43/4/518.full
84)
The
mortality warning accompanies the original drug cautions, but in 2010, the FDA
repeated the warning in a special safety announcement. www.fda.gov/Drugs/DrugSafety/ucm224370.htm
85)
Lewis,
Kim. “Persister Cells.” Annu. Rev. Microbiol. 2010, 64:357-372. Online
at www.northeastern.edu/adc/publications.php
86)
Banerjee
B, Petersen K. “Psychosis following mycoplasma pneumonia.” Mil Med. 2009
Sep;174(9):1001-4.
87)
Krause
D, Matz J, et al. “The association of infectious agents and schizophrenia.” World
J Biol Psychiatry. 2010 Aug;11(5):739-43.
88)
Müller
N, Riedel M, et al. “Mycoplasma pneumoniae infection and Tourette's syndrome.”`
Psychiatry Res. 2004 Dec 15;129(2):119-25.
89) A fine overview entitled
“Autoimmune Illnesses and Degenerative Diseases” by Prof. Garth Nicolson can
be found at www.immed.org/illness/
autoimmune_illness_research.html.
90)
Nicolson GL, Nasralla MY, Haier J, Erwin R, Nicolson NL, and
Ngwenya R. “Mycoplasmal Infections in Chronic Illnesses: Fibromyalgia and
Chronic Fatigue Syndromes, Gulf War Illness, HIV-AIDS and Rheumatoid
Arthritis.” Medical Sentinel 1999; 4:172-176.
91)
References
at immed.org: J Amer Nutraceut Assoc 2003; 6(3):22-28 Pathol Oncol
Res 2005; 11:139-144 J Chronic Fatigue Synd 2006; 13(4):57-68 J
Amer Nutraceut Assoc 2010; 13(1):11-15.
92)
Nicolson,
GL. “Systemic Intracellular Bacterial Infections (Mycoplasma, Chlamydia,
Borrelia species) in Neurodegenerative (Multiple Sclerosis, Amyotrophic Lateral
Sclerosis, Alzheimer's) and Behavioral (Autistic Spectrum Disorders) Diseases”
Online at www.townsendletter.com/April2008/systemicintracel_notes0408.htm
93)
refer to our website (www.RA-Infection-Connection.com) and peruse
many articles on vitamin C
94)
Linker
III, Joe B. and Williams Jr., Ralph C.
“Tests for Detection of Rheumatoid Factors,” in Rose (1986) pp. 759-761.
95)
Repeated
stimulus of the immune system with TB test materials can significantly extend
the life of melanoma patients. This treatment was given to a family friend
whose life was saved as a result.
96)
Tully,
Dr. J. G. “Reflections: Some Personal Impressions of Early Life and Forty Years
of Mycoplasmology.” Prepared for the Archives of the International Organization
for Mycoplasmology upon his retirement from the National Institutes of Health
in 2001.
97)
See
www.thearthritiscenter.com/arthritis_info.htm#Anchor-Infections-11481.
98)
http://emedicine.medscape.com/article/961063-overview
(2010)
99)
www.cdc.gov/ncidod/dvrd/revb/respiratory/parvo_b19.htm
100)
http://labtestsonline.org/understanding/analytes/parvo/tab/test
(2009)
101)
Cassinotti
P, et al. “Presence and significance of human parvovirus B19 DNA in synovial
membranes and bone marrow from patients with arthritis of unknown origin.” J
Med Virol. 1998 Nov;56(3):199-204. Online at http://www.ncbi.nlm.nih.gov/pubmed/9783685
102)
Written
testimony of Dr. Garth L. Nicolson to the Congressional Committee on Government
Reform (Subcommittee on National Security, Veterans’ Affairs and International
Relations), January 24, 2002.
103)
National
Academies Report: “Gulf War Service
Linked to Post-Traumatic Stress Disorder, Multisymptom Illness, Other Health
Problems, But Causes Are Unclear.” April, 2010. Online at http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12835
104) Hilborne and Golomb (2001)
pg 9.
105)
Steele
L, Sastre A, et al. “Complex Factors in the Etiology of Gulf War Illness:
Wartime Exposures and Risk Factors in Veteran Subgroups.” Environmental
Health Perspectives, 2011. Online at http://www.sciencedaily.com/releases/2011/09/110919074247.htm
106)
Also
Nicolson GL, Nasralla MY, et al. “High frequency of systemic mycoplasmal
infections in Gulf War veterans and civilians with Amyotropic Lateral Sclerosis
(ALS).” Journal of Clinical Neuroscience 2002;9;525-9)
107)
www.anthrax.osd.mil/resource/qna/qaAll.asp?cID=313
108)
Gherardi
RK. “Lessons from macrophagic myofasciitis: towards definition of a vaccine
adjuvant-related syndrome.” Rev Neurol (Paris). 2003 February 159(2):162-4.
109)
Dr.
Alan Cantell, Jr., M.D. Are Vaccines Causing More Disease Than They Are
Curing?” http://www.gulfwarvets.com/vexing.htm
(1999)
110)
www.immunizeforgood.com/fact-or-fiction/too-many-too-soon
(2010)
111)
www.fourteenstudies.org/history.html
112)
Blaylock
RL.” Chronic microglial activation and excitotoxicity secondary to excessive
immune stimulation: Possible factors in Gulf War Syndrome and Autism.” J
Amer Phys Surg 2004; 9: 46-51. Online at http://www.nationalautismassociation.org/pdf/blaylockvaccinepaper.pdf
113)
www.cdc.gov/vaccines/programs/vfc/cdc-vac-price-list.htm#flu
(2011)
114)
At
this writing, there are actually 19 studies referred to by “experts” as
providing “overwhelming evidence.”
115)
“International
Medical Council on Vaccination refutes vaccine propaganda with myth-busting
report.” Free downloadable 2011 report at www.naturalnews.com/031173_vaccines_science.html
116)
For
the CDC’s point of view, see www.cdc.gov/vaccinesafety/Vaccines/multiplevaccines.html
(2011)
117) See these websites for more
information on ASD: www.autism-society.org , www.autismspeaks.org/site-wide/cure-autism-now , www.delimmune.com/research/improvements-in-gastrointestinal-symptoms-among-children-with-autism/ , www.ninds.nih.gov/disorders/autism/detail_autism.htm , http://blog.ehealthmedicare.com/media-center/infographics/?pid=1 , www.helpguide.org/mental/autism_help.htm , http://safesoundfamily.com/p/autism-safety/ , and www.immed.org for ongoing research.
118)
www.pdhealth.mil/deployments/gulfwar/brucellosis.asp
119)
“Health Consequences of Service During the Persian Gulf War:
Recommendations for Research and Information Systems.” Testimony given by Dr.
Garth Nicolson to the Congressional Committee to Review the Health Consequences
of Service During the Persian Gulf War, Washington, DC, 1996.
120)
Thomas
JL, Wilk JE, et al. “Prevalence of Mental Health Problems and Functional Impairment
Among Active Component and National Guard Soldiers 3 and 12 Months Following
Combat in Iraq.” Arch Gen Psychiatry. 2010;67(6):614-623. Online
at http://archpsyc.ama-assn.org/cgi/content/full/67/6/614
121)
Interview
comments to Dr. Roger G. Mazlen, host of the Chronic Fatigue Syndrome Radio
Show, January 4, 1998.
122)
Dr.
Nicolson’s daughter served in the Gulf as a helicopter pilot. Her complaints of
unusual joint pain and fatigue piqued Dr. Nicolson’s interest in the cause of
these symptoms, and led him and his wife Nancy (also a health professional) to
the in-depth investigation of GWI, research into pathogenic Mycoplasma strains,
and eventually the establishment of a world class infectious organism testing facility in California.
123)
Nicolson GL, Nasralla MY, Berns P, Haier, J. “Chronic Mycoplasmal Infections in
Autism Patients.” Institute for Molecular Medicine, Huntington Beach, CA.
(2000).
124)
www.canlyme.com/autismlyme.html
125)
http://emedicine.medscape.com/article/223609-overview
(2011)
126) Nasralla M.; Haier, J. and
Nicolson, G.L. “Multiple Mycoplasmal Infections Detected in Blood of Chronic
Fatigue and Fibromyalgia Syndrome Patients.” Eur J Clin Microbiol Infect Dis
18:359-365, 1999.
127)
Vojdani
A, Franco AR. “Multiplex PCR for the Detection of Mycoplasma fermentans, M.
hominism, and M. penetrans in Patients with Chronic Fatigue Syndrome,
Fibromyalgia, Rheumatoid Arthritis, and Gulf War Syndrome.” Journal of
Chronic Fatigue Syndrome Vol. 5,
No. 3/4, 1999, pp. 187-197. Online at
www.thearthritiscenter.com/pub_multiplex.htm
128)
Cretney
E, McQualter JL, et al. “TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L
suppresses experimental autoimmune encephalomyelitis in mice.” Immunology
and Cell Biology (2005) 83, 511–519. www.nature.com/icb/journal/v83/n5/full/icb200569a.html
129)
Yamamoto,
Y. “PCR in Diagnosis of Infection: Detection of Bacteria in Cerebrospinal
Fluids.” Clin Diagn Lab Immunol. 2002 May; 9(3): 508–514
130)
www.webmd.com/multiple-sclerosis/guide/multiple-sclerosis-spinal-tap.
(2010)
131)
www.lef.org/protocols/neurological/multiple_sclerosis_01.htm
(2010)
132)
www.thisisms.com/forum/antibiotics-f28/topic6403.html
133)
Stratton,
C; Mitchell, W; Sriram, S. “Does Chlamydia
pneumoniae Play a Role in the Pathogenesis of Multiple Sclerosis? J Med
Microbiol 2000 Jan;49(1):1-3.
134)
Sriram,
S; Mitchell, W. and Stratton, C.
“Multiple Sclerosis Associated with Chlamydia pneumoniae
Infection of the CNS.” Neurology
1998 Feb;50(2):571-2
135)
David
Wheldon MB FRCPath. “Empirical antibacterial treatment of infection with Chlamydophila
pneumoniae in Multiple Sclerosis.” (2009).
136)
Dr.
Lindner’s research is found on the ThisIsMS support group site: www.thisisms.com/forum/antibiotics-f28/topic572.html (2004)
137)
Nicolson,
G.L. and Nicolson, N.L. “Autoimmune Neurological and Rheumatic Diseases: Role
of Chronic Infections in Morbidity and Progression.” Proceedings 13th
International Symposium on Integrative Medicine 2001; 13:104-112.
138)
Ablashi
DV, Lapps W, et al. “Human Herpes Virus-6 (HHV-6) Infection In Multiple
Sclerosis.” Mult Scler 1998 Dec;4(6):490-6.
139)
Many
research references at www.hhv-6foundation.org/associated-conditions/hhv-6-and-multiple-sclerosis
140)
See
www.cdc.gov/ncidod/eid/vol5no3/campadelli.htm
for collected CDC studies online (1999)
141)
www.publichealthalert.org/Articles/scottforsgren/mycoplasma.htm
and http://articles.mercola.com/sites/articles/archive/2001/09/08/mycoplasma.aspx
142)
For
more information, contact the National Multiple Sclerosis Society, NY, NY. www.nationalmssociety.org/index.aspx
143)
Naubauer,
RA. “Protocol for the Treatment of Multiple Sclerosis with Hyperbaric Oxygen.” J.
Hyperbar Med 1990; 5:53-54.
144)
Vitamin
C is also effective against and Human papillomavirus
(HPV). See www.doctoryourself.com/herpes.html
(2007)
145)
http://emedicine.medscape.com/article/395381-overview
(2011)
146)
Reported
Tuberculosis in the United States, 2009. Executive Commentary.” Online at
www.cdc.gov.
147)
www.nyc.gov/html/doh/downloads/pdf/tb/tb-control-kambili.pdf
(2010)
148)
Bloom
BR. Public Health in Transition. Sci Am. 2005; 293(3):92-9.
149)
See
www.lef.org/protocols/neurological/als_01.htm
for an overview of symptoms, tests, and treatments. Also, contact the nonprofit ALS Association National Office at www.alsa.org.
150)
"ALS
(Amyotrophic Lateral Sclerosis) Fact Sheet," NINDS. February 2010. NIH
Publication No. 10-916. Online at www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail_ALS.htm
151)
Statistics
and research available at www.immed.org.
152)
Nicolson,
GL. Systemic Intracellular Bacterial Infections (Mycoplasma, Chlamydia,
Borrelia species) in Neurodegenerative (Multiple Sclerosis, Amyotrophic Lateral
Sclerosis, Alzheimer's) and Behavioral (Autistic Spectrum Disorders) Diseases.”
In the Townsend Letter, April 2008.
153)
Berger
MM, Kopp N, et al. “Detection and Cellular Localization of Enterovirus RNA
Sequences in Spinal Cord of Patients with ALS.” Neurology 2000;
54:20-25. Also Nicolson GL, Nasralla M, and Nicolson N. “The Pathogenesis and
Treatment of Mycoplasmal Infections.” Antimicrob Infect Dis Newsl
1999; 17:81-88.
154)
Johnson
R, Schell R, Waisbren B. “Borrelia burgdorferi Antibodies and
Amyotrophic Lateral Sclerosis.” Lancet, August 8, 1987. In this article,
reference is made to Drs. Stanek, Pachner Reik, Steere and Dattwyler, who
actively downplayed Lyme at the time.
155)
Halperin,
JJ, MD, Kaplan, GP, MD, et al. “Immunologic Reactivity Against Borrelia
burgdorferi in Patient with Motor Neuron Disease.” Archives of Neurology,
Vol 47, May 1990.
156)
Hansel
Y, Ackerl M, Stanek G. “ALS-like sequelae in chronic neuroborreliosis.” Wien
Med Wochenschr, 1995; 145(7-8):186-8.
157)
Binfaré,
RW, et al. “Ascorbic acid administration produces an antidepressant-like
effect: Evidence for the involvement of monoaminergic neurotransmission.” Progress
in Neuro-Psychopharmacology & Biological Psychiatry (ISSN 0278-5846)
Impact factor: 2.823, v. 33, p. 530-540, 2009.
158) MMWR Surveill Summ. 2009 Dec
18;58(10):1-20.[45 collaborators]. “Prevalence of autism spectrum disorders -
Autism and Developmental Disabilities Monitoring Network, United States, 2006.”
Online at www.cdc.gov/mmwr/preview/mmwrhtml/ss5810a1.htm
159)
See
a free online video of an Autism Research Institute 2011 presentation “Autism
as a Multisystem, Whole-Body Disorder” at http://www.ariconference.com/.
160)
http://www.tacanow.org/family-resources/latest-autism-statistics-2/
(2011)
161)
www.autism.net.au/Autism_causes.htm
and http://psychology.uwo.ca/autism.htm
162)
www.cdc.gov/ncbddd/autism/data.html
163)
www.researchautism.net/interventionitem.ikml?print&ra=67&infolevel=4
164)
Rossignal
DA, Rossignol LW. “Hyperbaric oxygen therapy may improve symptoms in autistic
children.” Medical Hypotheses (2006) http://sirricenter.com/pdfs/HBOT_autism.pdf
165)
Rossignal
DA, Rossignol LW, et al. “Hyperbaric treatment for children with autism: a
multicenter, randomized, double-blind, controlled trial.” BMC Pediatrics 2009, 9:21. Online at www.biomedcentral.com/1471-2431/9/21
166)
Nicolson
GL, Gan R, Nicolson NL, Haier J. “Evidence for Mycoplasma ssp., Chlamydia
pneunomiae, and human herpes virus-6 coinfections in the blood of patients
with autistic spectrum disorders.” J Neurosci Res. 2007
Apr;85(5):1143-8.
167)
Besides
Dr. Nicolson’s considerable research at www.immed.org, also see www.ageofautism.com/2011/04/the-potential-importance-of-the-xmrv-retrovirus-to-autism.html
168)
www.whale.to/y/autism_vitA.html
(1999)
169)
Cannell
JJ. “On the aetiology of autism.” Acta Pædiatrica 2010 99, pp.
1128–1130. Also Levenson CW, Figueiroa SM. “Gestational vitamin D deficiency:
long-term effects on the brain.” Nutr Rev 2008; 66:726–9.
170)
http://drclark.typepad.com/dr_david_clark/2010/06/new-research-autism-vitamin-deficiency-.html (2010)
171)
Annweiler
C, Schott AM, et al. “Association of vitamin D deficiency with cognitive
impairment in older women: cross-sectional study.” Neurology. 2010 Jan
5;74(1):27-32.
172)
Knekt P, Kilkkinen A, et al. “Serum Vitamin D and
the Risk of Parkinson Disease.” Arch Neurol. 2010;67(7):808-811
173)
http://autism-nutrition.com/vitamin-b12-autism
(2011)
174)
www.psychology.uwo.ca/autism/index.htm
175)
Parracho
M, et al. “Differences between the gut microflora of children with autistic
spectrum disorders and that of healthy children.” J. Med. Microbiol. 54,
987-991 (2005)
176)
http://pptu.lefora.com/2010/12/01/pptu-autism-asd/.
Study done by Metametrix.
177)
Valicenti-McDermott
M, et al. “Frequency of gastrointestinal symptoms in children with autistic
spectrum disorders and association with family history of autoimmune
disease.” J. Dev. Behav. Pediatr.
27, S128-36 (2006)
178)
Frigsman
A, et al. “Clinical Presentation and Histologic Findings at Ileocolonoscopy in
Children with Autistic Spectrum Disorder and Chronic Gastrointestinal
Symptoms.” Autism Insights 2010:2 1-11. Online at www.la-press.com/clinical-presentation-and-histologic-findings-at-ileocolonoscopy-in-ch-article-a1816
179)
Diaz
Heijtz R, et al. “Normal gut microbiota modulates brain development and
behavior.” Proc. Natl. Acad. Sci. (2011)
180)
Unattributed,
from the Behavioural Neurothrapy Clinic, Doncaster, Victoria, Australia.
“Cellular malnutrition and Intestinal Dysbiosis in Autism.” Online at www.adhd.com.au/Intestinal_Dysbiosis.htm
(2010)
181)
Fasano,
Dr. Alessio. Presentation at April 2010 DAN! Conference in Baltimore, MD.
“Intestine, Leaky Gut, and Autism: A Serendipitous Association of a Planned
Design?”
182)
Vojdani
A, “A Gut Feeling for Immune Dysregulation & Neuroinflammation in Autism”
(2008). Online at http://www.immunoscienceslab.com/Articles/A%20Gut%20Feeling%20US.pdf
183)
www.eastvalleynd.com/specialty-labs/igg-food-intolerance-testing-.html
184)
www.newautism.com/new-study-claims-vaccines-are-safe-is-it-true/1293/
185)
See collected research at http://www.ra-infection-connection.com/KalokerinosAA-VaccinesRefs.htm
186)
http://www.hhs.gov/news/press/2011pres/02/20110216b.html
187)
Graham
M, Edwards MJ. “Teratogen Update: Gestational Effects of Maternal Hyperthermia
Due to Febrile Illnesses and Resultant Patterns of Defects in Humans.” Teratology
58: 209–21. 1998.
188)
Conversation
with Dr. Hawkins Kirk, February, 2011.
189)
www.inchem.org/documents/ehc/ehc/ehc22.htm
(1982)
190)
Hynynen
K, et al. “Potential adverse effects of high-intensity focused ultrasound
exposure on blood vessels in vivo.” Online at www.sciencedirect.com/science/article/pii/0301562995020446
191)
www.centrus.com.br/DiplomaFMF/SeriesFMF/doppler/capitulos-html/chapter_02.htm
(2002) and also www.fetalultrasoundsafety.net
192)
www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PatientAlerts/ucm064756.htm
193)
Rados,
Carol. 2004. FDA Cautions Against Ultrasound "Keepsake" Images. FDA
Consumer Magazine. www.fda.gov/fdac/features/2004/104_images.html.
194)
Barnard,
J, et al. "Autism in schools: Crisis or challenge?" The National
Autistic Society. Full report online at http://www.autism.org.uk/~/media/nas/documents/about-autism/autism-library/magazines-articles-and-reports/reports/our-reports/autism%20in%20schools%20%20crisis%20or%20challenge%20full%20report.ashx
195)
John
Stone. “UK Government Farce Over New Adult Autism Study.” http://www.ageofautism.com/2009/09/uk-government-farce-over-new-adult-autism-study-.html.
Coverups appear to be worldwide. See collected
research at http://www.ra-infection-connection.com/KalokerinosAA-VaccinesRefs.htm
196)
www.midwiferytoday.com/articles/ultrasoundrodgers.asp
197)
Excellent
examples are www.Autism360.org and
www.AutismSpeaks.org . Case studies and therapy information can be found at www.AutismFile.com
198)
Kevin
Deane, MD. “Pneumococcal Vaccination in Patients With Rheumatic Diseases.” (2011)
www.medscape.com/viewarticle/738426
199)
http://virology-online.com/general/typesofvaccines.htm
200)
Details at www.ra-infection-connection.com/OilNutrnRevln.htm
201)
www.gatesfoundation.org/vaccines/Pages/default.aspx.
202)
http://research.msu.edu/stories/researcher-develops-vaccine-strain-e-coli (2009)
203) Longbottom, D. “Chlamydial vaccine development.” J Med Microbiol July 2003 vol. 52 no. 7 537-540; Levine MM, Kotloff KL, et al. “Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.” Nat Rev Microbiol. 2007 Jul;5(7):540-53; Atkins, HS, Morton, M, et al. “Recombinant Salmonella vaccines for biodefence.” Vaccine Volume 24, Issue 15, April 2006, pp. 2710-17; Prucca CG, Slavin I, et al. “Antigenic variation in Giardia lamblia is regulated by RNA interference.” Nature 456, 750-754 (11 Dec 2008) and Pechine S, Janoir C, et al. “Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of C. difficile.” Vaccine. May 2007.
204)
205)
Blaylock
RL, M.D..” The danger of excessive vaccination during brain development: the
case for a link to Autism Spectrum Disorders (ASD).” This 2008 article and all
Dr. Blaylock’s published papers and articles can be found on his website, www.russellblaylockmd.com.
206)
Prandota
J. "Urinary Tract Diseases Revealed after DTP Vaccination in Infants and
Young Children." American Journal of Therapeutics. 2004;
11(5):344-353.
207)
Pukhalsky
AL, et al. “Cytokine profile after rubella vaccine inoculation: evidence of the
immunosuppressive effect of vaccination.” Mediators Inflamm. 2003
August; 12(4): 203–207.
208)
http://www.cdc.gov/nchs/data/databriefs/db23.htm
209)
Alderslade
R., et al. “Report of the National Childhood Encephalopathy Study.” Report by
the Committee on the Safety of Medicines and the Joint Committee on Vaccination
and Immunisation 1981. Whooping cough. London: HMSO, 1981:79-169.
210)
Bernsen
R, M.D., et al. “Reported pertussis infection and risk of atopy in 8- to
12-yr-old vaccinated and nonvaccinated children.” Pediatr Allergy Immunol.
Feb 2008;19;46-52.
211)
www.mpwhi.com/vaccine_information.htm
offers an eclectic mix of credible and unsupported advocacy articles. This URL
is intended for information only, to illustrate the heated controversy
surrounding vaccines. Another collection of more than 1,000 studies on
vaccination injuries and failures (2002) can be found at www.webalice.it/mymmouth/Doc/Vaccini/10000studisuidannidavaccino.pdf.
The authors of this book do not endorse all material presented.
213)
http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm187810.htm
(2011)
214)
www.nvic.org/Myths-and-Facts.aspx
215)
Presentation
“Controversies in Vaccinations” at the 2011 IFM International Symposium in
Bellevue, WA.